Correlation Between Freeline Therapeutics and Akari Therapeutics

Can any of the company-specific risk be diversified away by investing in both Freeline Therapeutics and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Freeline Therapeutics and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Freeline Therapeutics Holdings and Akari Therapeutics PLC, you can compare the effects of market volatilities on Freeline Therapeutics and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Freeline Therapeutics with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Freeline Therapeutics and Akari Therapeutics.

Diversification Opportunities for Freeline Therapeutics and Akari Therapeutics

0.0

Correlation Coefficient

Freeline Therapeutics  Akari Therapeutics

Pay attention - limited upside

The 3 months correlation between Freeline and Akari is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Freeline Therapeutics Holdings and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Freeline Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Freeline Therapeutics Holdings are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Freeline Therapeutics i.e., Freeline Therapeutics and Akari Therapeutics go up and down completely randomly.

Pair Corralation between Freeline Therapeutics and Akari Therapeutics

If you would invest (100.00) in Freeline Therapeutics Holdings on December 3, 2024 and sell it today you would earn a total of  100.00  from holding Freeline Therapeutics Holdings or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Freeline Therapeutics Holdings  vs.  Akari Therapeutics PLC

Freeline Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Freeline Therapeutics Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy essential indicators, Freeline Therapeutics is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Akari Therapeutics PLC

Risk-Adjusted Performance

Very Weak

Over the last 90 days Akari Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Freeline Therapeutics and Akari Therapeutics

The main advantage of trading using opposite Freeline Therapeutics and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Freeline Therapeutics position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.

The idea behind Freeline Therapeutics Holdings and Akari Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.